FNBT
ITRM

FineMark National Bank & Trust’s Iterum Therapeutics ITRM Stock Holding History

FineMark National Bank & Trust’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,000
Closed -$168K – 472
2021
Q3 		$168K Hold
20,000
– – 0.01% 429
2021
Q2 		$693K Hold
20,000
– – 0.03% 256
2021
Q1 		$423K Buy
+20,000
New +$476K 0.02% 304

Other funds holding ITRM

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

FineMark National Bank & Trust's ITRM Position: Q4 2021 in Review

FineMark National Bank & Trust sold out of Iterum Therapeutics (ITRM) in Q4 2021, closing a stake of 20,000 shares — an estimated $168K sold.

FineMark National Bank & Trust first reported a position in ITRM in Q1 2021 and held it in 3 quarters. The position peaked at $693K in Q2 2021. 44 funds tracked by Wall St. Rank hold ITRM as of Q4 2021.

  • FineMark National Bank & Trust reported no remaining Iterum Therapeutics position as of Q4 2021 after selling out during the quarter.
  • FineMark National Bank & Trust sold 20,000 Iterum Therapeutics shares in Q4 2021, an estimated $168K.
  • FineMark National Bank & Trust first reported a position in Iterum Therapeutics in Q1 2021 and held it in 3 quarters.
  • FineMark National Bank & Trust's Iterum Therapeutics position peaked at $693K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q4 2021.

Based on FineMark National Bank & Trust's 13F filing for Q4 2021, filed 14 Feb 2022.